搜尋結果
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully ...
CNBC· 14 小時前After a two-year dry spell, initial public offerings by biotech companies showed signs of life ...
CNBC Exclusive: CNBC Transcript: Perplexity Founder & CEO Aravind Srinivas Speaks with CNBC’s ...
CNBC· 16 小時前Following is the unofficial transcript of a CNBC exclusive interview with Perplexity Founder & CEO Aravind Srinivas on CNBC's ...